Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Cancer Prev Res (Phila). 2015 Aug 14;8(10):942–951. doi: 10.1158/1940-6207.CAPR-15-0125

Figure 2.

Figure 2

Plasma soy isoflavone (genistein and daidzein combined) at baseline and after 12 months of intervention (Red= soy group; green= placebo group) (gndz_0: genistein and daidzein combined at baseline; gndz_1: genistein and daidzein combined at the end of month 12)